Autor Deborah M. — SEC insider filings
SEC reporting owner CIK 1884671. 28 insider filings on record with FilingPulse; latest filed 2026-11-18.
Transaction summary — filings shown
Covers all 28 filings on record, filed 2021-12-28 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 6 filings — 160,474 shares, $2,208,351 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 44.
- Largest priced transaction: sale of 16,773 shares @ $27.85 ($467,128) in Hims & Hers Health, Inc., filed 2026-08-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Hims & Hers Health, Inc. (HIMS) | Chief Policy Officer, Director | 14 | — | 3 legs · 47,655 sh · $1,167,613 | 24 |
| Amneal Pharmaceuticals, Inc. (AMRX) | Director | 10 | — | 5 legs · 112,819 sh · $1,040,738 | 13 |
| PARDES BIOSCIENCES, INC. (PRDS) | Director | 4 | — | — | 7 |
Insider filings — Autor Deborah M.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | Hims & Hers Health, Inc. (HIMS) | Sale (S): 23,828 @ $18.53 | EDGAR |
| 2026-11-17 | 4 | Hims & Hers Health, Inc. (HIMS) | Option exercise (M): 39,974 · Tax withholding (F): 16,146 @ $19.73 · Option exercise (M): 32,919 (derivative) @ $0 · Option exercise (M): 7,055 (derivative) @ $0 | EDGAR |
| 2026-08-20 | 4 | Hims & Hers Health, Inc. (HIMS) | Sale (S): 16,773 @ $27.85 | EDGAR |
| 2026-08-18 | 4 | Hims & Hers Health, Inc. (HIMS) | Option exercise (M): 32,920 · Tax withholding (F): 16,147 @ $28.15 · Option exercise (M): 32,920 (derivative) @ $0 | EDGAR |
| 2026-08-14 | 4 | Hims & Hers Health, Inc. (HIMS) | Grant/award (A): 8,223 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Hims & Hers Health, Inc. (HIMS) | Option exercise (M): 32,919 · Tax withholding (F): 15,396 @ $30.17 · Option exercise (M): 32,919 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Hims & Hers Health, Inc. (HIMS) | Option exercise (M): 3,656 · Option exercise (M): 3,656 (derivative) @ $0 | EDGAR |
| 2026-05-12 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Sale (S): 34,819 @ $12.94 | EDGAR |
| 2026-05-08 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 34,819 · Option exercise (M): 34,819 (derivative) @ $0 · Grant/award (A): 19,824 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Hims & Hers Health, Inc. (HIMS) | Option exercise (M): 32,919 · Tax withholding (F): 11,312 @ $24.77 · Option exercise (M): 32,919 (derivative) @ $0 | EDGAR |
| 2026-03-13 | 4 | Hims & Hers Health, Inc. (HIMS) | Grant/award (A): 526,711 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | Hims & Hers Health, Inc. (HIMS) | Sale (S): 7,054 @ $36.71 | EDGAR |
| 2025-12-16 | 4 | Hims & Hers Health, Inc. (HIMS) | Option exercise (M): 7,054 · Option exercise (M): 7,054 (derivative) @ $0 | EDGAR |
| 2025-08-08 | 4 | Hims & Hers Health, Inc. (HIMS) | Grant/award (A): 3,656 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Hims & Hers Health, Inc. (HIMS) | Option exercise (M): 6,175 · Option exercise (M): 6,175 (derivative) @ $0 | EDGAR |
| 2025-05-08 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 40,258 · Option exercise (M): 40,258 (derivative) @ $0 · Grant/award (A): 34,819 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Sale (S): 6,771 @ $8.41 · Sale (S): 33,229 @ $8.34 | EDGAR |
| 2024-11-19 | 4 | Hims & Hers Health, Inc. (HIMS) | Grant/award (A): 21,164 (derivative) @ $0 · Grant/award (A): 6,175 (derivative) @ $0 | EDGAR |
| 2024-05-20 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Sale (S): 14,553 @ $6.76 · Sale (S): 23,447 @ $6.73 | EDGAR |
| 2024-05-14 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 76,453 · Option exercise (M): 76,453 (derivative) @ $0 | EDGAR |
| 2024-05-06 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Grant/award (A): 40,258 (derivative) @ $0 | EDGAR |
| 2023-08-31 | 4 | PARDES BIOSCIENCES, INC. (PRDS) | Disposition to issuer (D): 37,500 (derivative) · Disposition to issuer (D): 70,390 (derivative) · Disposition to issuer (D): 75,000 (derivative) · Disposition to issuer (D): 37,500 (derivative) | EDGAR |
| 2023-08-01 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 54,949 · Option exercise (M): 54,949 (derivative) @ $0 | EDGAR |
| 2023-06-02 | 4 | PARDES BIOSCIENCES, INC. (PRDS) | Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2023-05-11 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Grant/award (A): 76,453 (derivative) @ $0 | EDGAR |
| 2022-08-02 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Grant/award (A): 54,949 (derivative) @ $0 | EDGAR |
| 2022-06-10 | 4 | PARDES BIOSCIENCES, INC. (PRDS) | Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2021-12-28 | 4 | PARDES BIOSCIENCES, INC. (PRDS) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1884671 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs